INTRODUCTION
Genetic immunization is a relatively new tool for achieving specific immune activation with several advantages such as expression of concerned genes nearest to its native form, induction of cellular immune response, persistent expression of desired antigen (Ag) and induction of memory responses against the infectious disease (1) . Moreover, host cells take up coding plasmids, transcribe and translate the encoded gene, and produce protein that stimulates an immune response when presented to the immune system in the context of self-MHC (2) . Notably, vaccination with plasmid DNA has been shown to induce protective immunity through both MHC class I-and class II-restricted T cell responses in a variety of infections (3) . Therefore, the plasmid DNA encoding specific Ag induced both CD4 + and CD8 + T cells, which is essential for protection against intracellular diseases that require cell mediated immunity like leishmaniasis (4) .
DNA vaccines may provide better protection against Leishmania than killed or live-attenuated vaccines as they can induce the expression of Leishmania antigens, which are unaltered in their protein structure and antigenicity. Furthermore, bacteriaderived DNA plasmids are naturally immunogenic as their backbones contain unmethylated cytosine-phosphate-guanosine (CpG) motifs which have been shown to readily induce Th 1 cytokine expression and enhance CD8 + T cell responses (5) .
However, at present, there is no effective vaccine available anywhere in the world for routine use against leishmaniasis (6) . The ineffectiveness of existed Leishmania vaccines is most likely due to the lack of consistent stimulation of helper T cells, a requirement for long-lived protection that usually occurs in response to natural and low profile persistent infections (7) . New antigens with such properties to stimulate memory T helper cells, a perquisite for a potent and lasting immunity, are still in need for constructing effective new vaccines (8) .
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The major surface glycoprotein of Leishmania major is a zinc metalloproteinase of 63 kDa referred to as leishmanolysin or GP63, which is encoded by a family of seven genes. GP63, a highly conserved protein, is abundantly expressed in promastigotes, and considered the major Ag determinant recognized by the serum samples of patients obtained from different clinical forms of leishmaniasis, moreover GP63 has an intrinsic ability to stimulate protective immunity and is promising vaccine candidate against leishmaniasis (9) . It has been reported that the mode of administration of the DNA vaccine can influence the type of immune response induced by the vaccine. Intramuscular injection of naked DNA was one of the first method described for gene immunization which has been reported to lead the immune response toward Th 1 type while application of gen gun-mediated delivery, gold particles covered with plasmid DNA is very effective at driving plasmid into the cells of the epidermis and requires far less DNA than needle injection (10) .
MATERIALS AND METHODS

Animals and parasites
Fifty non pregnant female BALB/c mice (4-5 weeks old) were obtained from animal unit at College of Medicine/ University of Baghdad. Mice were bred in standard mice cages for ten weeks and fed on standard mice ration.
Ten ml vial frozen in liquid nitrogen contain L. major M379 strain (College of Science and Technology-Nottingham Trent University/ UK) was used in this study.
Parasite was grown in Drosophila Schneider media (Lonza), supplemented with 10% fetal calf serum (FCS) at 37ºC in CO 2 incubator for 24-48 hour. For parasite counting a volume of 10µl from the culture at specific time points was transferred to 1 ml eppendorf tube containing 90µl of 2% Paraformaldehyde. After mixing, 10µl of fixed parasites were transferred to a second eppendorf tube containing 90µl 1xPBS, and counted using Neubauer Hemocytometer.
Sampling procedure
After two weeks from the last vaccination, at least 1 ml blood sample was collected in1.5 micro-centrifuge tube from the heart of each mouse by using insulin syringe. Sera were obtained from blood samples by centrifugation and kept at -20 C for further investigation. Dumonteil et al (2003) with slight modification (11) .
Briefly, a number of 1~ 2*10 9 late log L. major M379 (stationary phase) was washed 3 times with sterile 1xPBS (4000 g at 4 ̊ C). Parasite pellet was then resuspended in Leishmania Buffer (a 100 mMTris pH 7.3 buffer with 1 mM EDTA, 0.5 mM Phenylmethanesulfonyl fluoride (PMSF) and 2.5 μg/ml Leupeptin -Sigma). The suspension was sonicated for 20 minutes. The sonicated pellet was centrifuged for 30 min at 13,000× rpm. Supernatant was dialysed against 3 litres of cold PBS for overnight with at least two changes of 1xPBS. SLA was sterilized by passing through 0.25 μm filters (Sartorius), and then kept at -20˚C for further investigations.
The total protein concentration of extracted protein was measured using
Bicinchoninic Acid Protein Assay Kit according to manufacturer's protocol.
Preparation of Leishmania major cDNA Assay Diluent was used to perform 2-fold serial dilutions of standards to make the standard curve. 100 μl/well of 1x Assay Diluent was added to the blank well. 100 μl/well of standards and serum samples were loaded to appropriate wells and the wells were covered and incubated at room temperature for 2 hours. Plate was washed as mentioned above. 100 μl/well of detection antibody (pre-titrated biotin-conjugated antibody) was added to each well. The plate was sealed and incubated at room temperature for 1 hour. Cover film was removed and the plate was washed as described previously. 100 μl/well of Avidin-HRP was added to each well and the plate was sealed and incubated for 30 minutes at room temperature. Plate was washed as in step 2 and repeated for total seven washes. 100 μl/well of substrate solution, tetramethylbenzidine (TMB), to each well and incubated for 15 minutes at room temperature. The reaction was stopped by adding 50 μl of stop solution to each well.
The absorbance of each well was read at 450 nm using microplate reader. 100μl of HRP conjugated goat anti-mouse IgG (Promega, UK) was added at 1:1000 followed by 1hour incubation at room temperature and 4 times washes. 100 μl/well of substrate solution to each well and incubated for 15 minutes at room temperature. The reaction was stopped by adding 100 μl of stop solution to each well. The absorbance of each well was read at 450 nm using microplate reader.
Optical denisity less than 0.2 considered as resprocal end-point IgG titer (defined as the inverse of the highest seum dilution factor giving an absorbance >0.2) against SLA (12) .
Statistical analysis
Data are expressed as the mean values ± standard deviation (SD) of samples.
The statistical significance of the differences between various groups was determined by PostHoc test (LSD alpha 0.05) and one-way analysis of variance (ANOVA) using SPSS for windows. Differences were considered statistically significant for p<0.05.
RESULTS
Amplification of lmajgp63 gene from original plasmid forward and revers primers 5'-TGTCGATATCCTATGCGTGGGCTGGA-3'
and 5'-TCTGAGATCTGGGGAGGGGTCACAGG-3' were used to amplify full length of lmajgp63, from lmajgp63/PNUT plasmid, with restriction sites for EcoRV and BgIII restriction enzymes by PCR. The result is shown in figure 2 .
Digestion of amplified lmajgp63 and lmexgp63/VR1012 by restriction enzymes
To obtain lmajgp63 gene with sticky ends to insert into empty VR1012 plasmid, two restriction enzymes, EcoRV and BgIII, were used to digest both gene and plasmid. The result is shown in figure 3 . (3, 11) . Using EcoRV restrection enzyme for digestion of gp63 resulting in split the resrection site at the forward end and devided the gene into two segaments (1273 bp and 622bp) due to the presence of the sequence GATATC at the site 627 which recognized by EcoRV enzyme as restriction site ( Figure 3 ) and because of that another step of re-ligation was needed to religated the gene by using ligase enzyme (Figure 4 ).
PCR cloning was carried out after PCR
The re-ligated lmajgp63 was inserted into VR1012 plasmid successfully using ligase enzyme and it was confirmed by PCR amplification using pair of primers mentioned above ( Figure 5 ). 
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Five primers were designed in this study by Primer 3 design plus sfotware for the sequencing of lmajgp63 gene in the newly prepared plasmid. The needing for that number of primers was due to the size of the gene. Results produced by Source Bioscience LTD, UK, were assembled using Just bio software and compared with the sequence of L. major gp63 gene in gene bank (Accession number Y00647) and they were identical except in base number 847 (C inspit of G) and base number 865 (G inspite of C) which represent minor mutation during PCR amplification (Figure 7) . Sharifian H. 2010, found that the ratio of mutants depends on the multiplication of the sequence length and mutation rate. The mutation rate is determined by the performance of the DNA polymerase. So using an accurate polymerase, about 98% of the sequences are amplified without mutation when they are not so long (e.g. 100 bp). But the probability to have mutants is higher for longer sequences (e.g. 1000 bp). Her results showed that about 12% of the generated sequences have one mutation even by using an accurate enzyme (13) .
To analyse the mutations result during amplification, allignment between amino acids produced by virtual translation of the sequence created in this study by using of Geneious Inspirational Software for Biologists and amino acid sequence published in gene bank for L. major gp63 protein (Accession number Y00647) was done. The result was both amino acid sequences were identical, i.e, the mutations were silent mutation (result is not shown). Point mutations were said to be "silent" when they do not affect the amino acid sequence of the protien. For example, a codon change from CGA to CGG dose not affect protien because both of these codons specify arginine (14) .
Many studies have been reported that resistant to Leishmania parasite infection is contributable to Th 1 immune responses (15, 16, 17) . In this study IL-2 and INF-γ concentration in mice sera were estimated to detect Th 1 response against DNA vaccines. According to IL-2 and INF-γ serum concentration, there were significant differences (p<0.05) between mice groups vaccinated with lmajgp63/VR1012 plasmid, administrated via I/D or I/M routes as DNA vaccines, and control groups (Figures 8 and 9) , that mean there are significant differences between vaccinated groups and control groups in stimulation of Th 1 cells. However there are no available data about using Dermojet needle-free injector as delivery system for DNA vaccination in mice to compare our results with them, needle-free vaccine delivery has been studied in numerous species including cats (19) , dogs (20) , cattle (21) and pigs (22) . The vast majority of needle-free studies demonstrated that needle-free intradermal DNA vaccine delivery resulted in an enhanced immune response when compared to traditional needle-and-syringe vaccine delivery for example Aguiar et al. (2001) found that rabbits vaccinated with 3 doses of plasmid encoding malarial antigen (Plasmodium falciparum circumsporozoite protein) by needle-free injection had 8 to 50 fold greater Ab titers than those injected intramuscularly with traditional needle-syringe device (23) . This discrepancy can be explained by that the skin is an active immune surveillance site and is rich in very potent antigen presenting dendritic cells (DCs) such as Langerhan's cells (LCs) in the epidermis and the immature DCs in the dermis (24) . DCs are thought to play at least three distinct roles in genetic immunization: (1) MHC class II-restricted presentation of antigens secreted by neighbouring, transfected cells, (2) MHC class I-restricted ''cross'' presentation of antigens released by neighbouring, transfected cells, and (3) direct presentation of antigens by transfected DCs themselves (25) .
Previous studies reported that plasmids are large molecules, and cell's cytoplasmic and nuclear membranes represent barriers to delivery of plasmids to the eukaryotic nuclei where plasmids are expressed. One promising mechanism to deliver DNA vaccines is the use of particle-mediated epidermal delivery (PMED) (1, 26, 27, 28) .
In PMED, the DNA plasmid is deposited onto a gold particle, and the gold particles are then accelerated through the skin using a compressed gas. Some of particles come to rest in the nuclei of cells, and the plasmids then elute off the particles and are expressed. The advantage of PMED for delivering plasmid DNA vaccines is the evident in that microgram quantities of plasmid can achieve strong immune responses, whereas much larger quantities of plasmid are typically needed to elicit a similar immune response using naked plasmid by intramuscular injection (29, 30, 31, 32, 33) .
Type two immune response (Th 2 ) was reported to be the main cause of susceptibility to Leishmania parasite infection in Balb/c mice (6) , therefor activation of (34) . 
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